The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in April, moving ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be ...

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.

K nowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions.